Maher El Chaar1, Jill Stoltzfus2, Leonardo Claros2, Tara Wasylik2. 1. Medical School of Temple University/St. Luke's University Health Network, 240 Cetronia Road, Suite 205, North Allentown, PA, 18104, USA. Maher.Elchaar@sluhn.org. 2. Medical School of Temple University/St. Luke's University Health Network, 240 Cetronia Road, Suite 205, North Allentown, PA, 18104, USA.
Abstract
BACKGROUND: Postoperative pain control in bariatric surgery is challenging, despite use of intravenous (IV) narcotics. IV acetaminophen is one pain control alternative. OBJECTIVE: The aim of this study was to investigate the economic impact of IV acetaminophen in bariatric surgery and its effect on patients' pain, satisfaction, and hospital length of stay. METHODS: In a randomized controlled trial, Group 1 (treatment) received IV acetaminophen plus IV narcotics 30 min before surgery, then medication plus IV narcotics/PO narcotics for the remaining 18 h. Group 2 (control) received IV normal saline plus IV/PO narcotics. Patients underwent laparoscopic Roux-en-Y gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (SG). Primary outcomes included direct hospital costs, length of stay, postoperative pain, and patient satisfaction. Secondary outcomes included indirect costs, rescue narcotics dosage, and 30-day outcomes. RESULTS:Mean direct hospital cost in the treatment group (n = 50) was $3089.18 versus $2991.62 for the control group (n = 50) (p > 0.05). Pain scores did not differ significantly (p = 0.61). After adjusting for surgery type, there was no significant difference in length of stay (p = 0.95). Significantly more control group patients incurred surgery-related indirect costs (10 versus 2%, p < 0.05), with greater presentation to the emergency department (ED) for abdominal pain (5/50 versus 1/50), yielding higher total indirect costs ($39,293 versus $13,185). CONCLUSIONS: Using IV acetaminophen for postoperative pain management produced notable indirect cost savings and reduced ED visits in the first 30 days postoperatively, with good safety and tolerance. Decreased statistical power may have accounted for certain non-significant findings.
RCT Entities:
BACKGROUND:Postoperative pain control in bariatric surgery is challenging, despite use of intravenous (IV) narcotics. IV acetaminophen is one pain control alternative. OBJECTIVE: The aim of this study was to investigate the economic impact of IV acetaminophen in bariatric surgery and its effect on patients' pain, satisfaction, and hospital length of stay. METHODS: In a randomized controlled trial, Group 1 (treatment) received IV acetaminophen plus IV narcotics 30 min before surgery, then medication plus IV narcotics/PO narcotics for the remaining 18 h. Group 2 (control) received IV normal saline plus IV/PO narcotics. Patients underwent laparoscopic Roux-en-Y gastric bypass (LRYGB) or laparoscopic sleeve gastrectomy (SG). Primary outcomes included direct hospital costs, length of stay, postoperative pain, and patient satisfaction. Secondary outcomes included indirect costs, rescue narcotics dosage, and 30-day outcomes. RESULTS: Mean direct hospital cost in the treatment group (n = 50) was $3089.18 versus $2991.62 for the control group (n = 50) (p > 0.05). Pain scores did not differ significantly (p = 0.61). After adjusting for surgery type, there was no significant difference in length of stay (p = 0.95). Significantly more control group patients incurred surgery-related indirect costs (10 versus 2%, p < 0.05), with greater presentation to the emergency department (ED) for abdominal pain (5/50 versus 1/50), yielding higher total indirect costs ($39,293 versus $13,185). CONCLUSIONS: Using IV acetaminophen for postoperative pain management produced notable indirect cost savings and reduced ED visits in the first 30 days postoperatively, with good safety and tolerance. Decreased statistical power may have accounted for certain non-significant findings.
Entities:
Keywords:
Bariatric surgery; Direct costs; Hospital length of stay; Indirect costs; Intravenous acetaminophen; Patient satisfaction; Postoperative pain control
Authors: Jon C Gould; K Craig Kent; Yin Wan; Victoria Rajamanickam; Glen Leverson; Guilherme M Campos Journal: J Am Coll Surg Date: 2011-10-13 Impact factor: 6.113
Authors: Mehraneh D Jafari; Fariba Jafari; Monica T Young; Brian R Smith; Michael J Phalen; Ninh T Nguyen Journal: Surg Endosc Date: 2013-08-13 Impact factor: 4.584
Authors: Matthew M Hutter; Bruce D Schirmer; Daniel B Jones; Clifford Y Ko; Mark E Cohen; Ryan P Merkow; Ninh T Nguyen Journal: Ann Surg Date: 2011-09 Impact factor: 12.969
Authors: Elaine M Burns; Haris Naseem; Alex Bottle; Antonio Ivan Lazzarino; Paul Aylin; Ara Darzi; Krishna Moorthy; Omar Faiz Journal: BMJ Date: 2010-08-26
Authors: Jonathan P Weiner; Suzanne M Goodwin; Hsien-Yen Chang; Shari D Bolen; Thomas M Richards; Roger A Johns; Soyal R Momin; Jeanne M Clark Journal: JAMA Surg Date: 2013-06 Impact factor: 14.766
Authors: Farrell E Cooke; Jon D Samuels; Alfons Pomp; Farida Gadalla; Xian Wu; Cheguevara Afaneh; Gregory F Dakin; Peter A Goldstein Journal: Obes Surg Date: 2018-10 Impact factor: 4.129
Authors: Erik M Helander; Bethany L Menard; Chris M Harmon; Ben K Homra; Alexander V Allain; Gregory J Bordelon; Melville Q Wyche; Ira W Padnos; Anna Lavrova; Alan D Kaye Journal: Curr Pain Headache Rep Date: 2017-01
Authors: Yung Lee; James Yu; Aristithes G Doumouras; Vahid Ashoorion; Scott Gmora; Mehran Anvari; Dennis Hong Journal: Obes Surg Date: 2019-04 Impact factor: 4.129
Authors: E Eve Shaffer; An Pham; Robert L Woldman; Andrew Spiegelman; Scott A Strassels; George J Wan; Thomas Zimmerman Journal: Adv Ther Date: 2016-11-09 Impact factor: 3.845